An Immunohistochemical Study of bcl-2 and p53 Protein Expression in Pancreatic Carcinomas
- 1 January 1998
- journal article
- Published by Informa UK Limited in Scandinavian Journal of Gastroenterology
- Vol. 33 (5), 535-539
- https://doi.org/10.1080/00365529850172124
Abstract
Only a few articles have examined the relationship between bcl-2 expression and clinical findings or bcl-2 expression and p53 expression in pancreatic carcinomas. We investigated bcl-2 protein and p53 protein expression by means of immunohistochemical methods. The immunostaining for bcl-2 was positive in 16 (20%) of 81 cases of pancreatic carcinoma. There were no significant correlations between bcl-2 expression and the age, gender, region of sampling, or clinical stage of the patients. Bcl-2 protein was detected more frequently in histologically high-grade pancreatic carcinomas (grade III, 31%; grade II, 14%; grade I, 0%); however, there was no significant difference in prognosis between patients with and without bcl-2 protein expression. Immunostaining for the p53 protein was positive in 45 (56%) of 81 cases of pancreatic carcinoma. There was no significant correlation between bcl-2 protein expression and p53 protein expression. Bcl-2 was often detected in histologically high-grade pancreatic carcinomas, although there was no significant correlation between bcl-2 expression and the prognosis.Keywords
This publication has 10 references indexed in Scilit:
- Clinical significance of serum p53 antigen in patients with pancreatic carcinomas.Gut, 1997
- DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2Cell, 1994
- Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tractZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- An Immunocytochemical Study of p53 and bcl-2 Protein Expression in Hodgkin’s DiseaseAmerican Journal of Clinical Pathology, 1993
- Apoptotic cell death induced by c-myc is inhibited by bcl-2Nature, 1992
- Bcl-2 initiates a new category of oncogenes: regulators of cell deathBlood, 1992
- Programmed cell death: Apoptosis and oncogenesisCell, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989